NeuriNox

Posted by peter on Feb 1, 2012 in News | Comments Off

Malin Hultqvist and Peter Olofsson attended the kick off meeting for the EU funded framework program NeuriNox in Geneva 23-24 january 2012. Redoxis will be part of this 5 year research program with the goal of R&D on neurodegenerative disorders to produce novel treatment for diseases like ALS and Multiple Sclerosis.